Citations (31)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Martina Montagnana, Elisa Danese, Giuseppe Lippi & Cristiano Fava. (2017) Blood laboratory testing for early prediction of preeclampsia: chasing the finish line or at the starting blocks?. Annals of Medicine 49:3, pages 240-253.
Read now
Read now
Articles from other publishers (30)
Tinnakorn Chaiworapongsa, Roberto Romero, Nardhy Gomez-Lopez, Manaphat Suksai, Dahiana M. Gallo, Eunjung Jung, Stanley M. Berry, Awoniyi Awonuga, Adi L. Tarca & David R. Bryant. (2023) Preeclampsia at term: evidence of disease heterogeneity based on the profile of circulating cytokines and angiogenic factors. American Journal of Obstetrics and Gynecology.
Crossref
Crossref
Tinnakorn Chaiworapongsa, Roberto Romero, Francesca Gotsch, Nardhy Gomez-Lopez, Manaphat Suksai, Dahiana M. Gallo, Eunjung Jung, Dustyn Levenson & Adi L. Tarca. (2023) One-third of patients with eclampsia at term do not have an abnormal angiogenic profile. Journal of Perinatal Medicine 51:5, pages 652-663.
Crossref
Crossref
Sapna Ramdin, Sooraj Baijnath, Thajasvarie Naicker & Nalini Govender. (2023) The Clinical Value of Rodent Models in Understanding Preeclampsia Development and Progression. Current Hypertension Reports 25:6, pages 77-89.
Crossref
Crossref
Tinnakorn Chaiworapongsa, Roberto Romero, Francesca Gotsch, Manaphat Suksai, Dahiana M. Gallo, Eunjung Jung, Arthur Krieger, Piya Chaemsaithong, Offer Erez & Adi L. Tarca. (2023) Preeclampsia at term can be classified into 2 clusters with different clinical characteristics and outcomes based on angiogenic biomarkers in maternal blood. American Journal of Obstetrics and Gynecology 228:5, pages 569.e1-569.e24.
Crossref
Crossref
H. Stepan, A. Galindo, M. Hund, D. Schlembach, J. Sillman, D. Surbek & M. Vatish. (2023)
Clinical utility of
sFlt
‐1 and
PlGF
in screening, prediction, diagnosis and monitoring of pre‐eclampsia and fetal growth restriction
. Ultrasound in Obstetrics & Gynecology 61:2, pages 168-180.
Crossref
Crossref
Dorota Sroka, Lisa-Antonia Lorenz-Meyer, Valerie Scherfeld, Julie Thoma, Andreas Busjahn, Wolfgang Henrich & Stefan Verlohren. (2023) Comparison of the Soluble fms-Like Tyrosine Kinase 1/Placental Growth Factor Ratio Alone versus a Multi-Marker Regression Model for the Prediction of Preeclampsia-Related Adverse Outcomes after 34 Weeks of Gestation. Fetal Diagnosis and Therapy 50:3, pages 215-224.
Crossref
Crossref
Jessica J. Miller, Victoria Higgins, Annie Ren, Samantha Logan, Paul M. Yip & Lei Fu. 2023.
103
161
.
Ravi Thadhani, Elizabeth Lemoine, Sarosh Rana, Maged M. Costantine, Vinicius F. Calsavara, Kim Boggess, Blair J. Wylie, Tiffany A. Moore Simas, Judette M. Louis, Jimmy Espinoza, Stephanie L. Gaw, Amy Murtha, Samantha Wiegand, Yvonne Gollin, Deepjot Singh, Robert M. Silver, Danielle E. Durie, Britta Panda, Errol R. Norwitz, Irina Burd, Beth Plunkett, Rachel K. Scott, Anna Gaden, Martha Bautista, Yuchiao Chang, Marcio A. Diniz, S. Ananth Karumanchi & Sarah Kilpatrick. (2022) Circulating Angiogenic Factor Levels in Hypertensive Disorders of Pregnancy. NEJM Evidence 1:12.
Crossref
Crossref
Leon J. Schmidt, Oliver Rieger, Mark Neznansky, Max Hackelöer, Lisa A. Dröge, Wolfgang Henrich, David Higgins & Stefan Verlohren. (2022) A machine-learning–based algorithm improves prediction of preeclampsia-associated adverse outcomes. American Journal of Obstetrics and Gynecology 227:1, pages 77.e1-77.e30.
Crossref
Crossref
Nikolina Docheva, Gabriel Arenas, Kristin M Nieman, Joana Lopes-Perdigao, Kiang-Teck J Yeo & Sarosh Rana. (2022) Angiogenic Biomarkers for Risk Stratification in Women with Preeclampsia. Clinical Chemistry 68:6, pages 771-781.
Crossref
Crossref
Sarah Heimberger, Joana Lopes Perdigao, Ariel Mueller, Gabriel Arenas, Melissa Kuriloff, Colleen Duncan, Courtney Amegashie & Sarosh Rana. (2022) Women’s perspectives and attitudes towards the utility of angiogenic biomarkers in preeclampsia. Pregnancy Hypertension 28, pages 109-113.
Crossref
Crossref
Stefan Verlohren, Shaun P. Brennecke, Alberto Galindo, S. Ananth Karumanchi, Ljiljana B. Mirkovic, Dietmar Schlembach, Holger Stepan, Manu Vatish, Harald Zeisler & Sarosh Rana. (2022) Clinical interpretation and implementation of the sFlt-1/PlGF ratio in the prediction, diagnosis and management of preeclampsia. Pregnancy Hypertension 27, pages 42-50.
Crossref
Crossref
Stefan Verlohren & Lisa-Antonia Dröge. (2022) The diagnostic value of angiogenic and antiangiogenic factors in differential diagnosis of preeclampsia. American Journal of Obstetrics and Gynecology 226:2, pages S1048-S1058.
Crossref
Crossref
S. Ananth Karumanchi, Sarosh Rana & Robert N. Taylor. 2022. Chesley's Hypertensive Disorders in Pregnancy. Chesley's Hypertensive Disorders in Pregnancy
165
185
.
Oriane Tasta, Olivier Parant, Safouane M. Hamdi, Mickael Allouche, Christophe Vayssiere & Paul Guerby. (2020) Evaluation of the Prognostic Value of the sFlt-1/PlGF Ratio in Early-Onset Preeclampsia. American Journal of Perinatology 38:S 01, pages e292-e298.
Crossref
Crossref
Lisa Antonia Dröge, Jonathan Eidmann, Annette Aigner, Lisa Frank, Frank-Holger Perschel, Wolfgang Henrich & Stefan Verlohren. (2021) Relevance of maternal sodium level for preeclampsia-associated adverse pregnancy outcomes. Pregnancy Hypertension 25, pages 110-115.
Crossref
Crossref
Jakob Gubensek, Rafael Ponikvar, Tanja Premru Srsen, Vesna Fabjan Vodusek, Manfred Georg Moertl & Miha Lucovnik. (2021) Therapeutic plasma exchange and dextran‐sulfate plasma adsorption as extracorporeal treatments of extremely preterm preeclampsia with fetal growth restriction. Journal of Clinical Apheresis 36:4, pages 595-605.
Crossref
Crossref
Guillaume Lefèvre, Alexandre Hertig, Jean Guibourdenche, Pacifique Lévy, Sophie Bailleul, Dominique Drouin, Florence Batusanski, Fabien Guimiot & Henri Boulanger. (2021) Decision-making based on sFlt-1/PlGF ratios: are immunoassay results interchangeable for diagnosis or prognosis of preeclampsia?. Clinical Chemistry and Laboratory Medicine (CCLM) 59:3, pages e87-e89.
Crossref
Crossref
V.M.M.M. Schiffer, C.W.J. Borghans, N. Arts, J.A.P. Bons, C.A.H. Severens-Rijvers, S.M.J. van Kuijk, M.E.A. Spaanderman & S. Al-Nasiry. (2021) The association between first trimester placental biomarkers and placental lesions of maternal vascular malperfusion. Placenta 103, pages 206-213.
Crossref
Crossref
Elisa Simón, Ignacio Herraiz, Cecilia Villalaín, Paula Isabel Gómez-Arriaga, María Soledad Quezada, Elena Ana López-Jiménez & Alberto Galindo. (2020) Correlation of Kryptor and Elecsys® immunoassay sFlt-1/PlGF ratio on early diagnosis of preeclampsia and fetal growth restriction: A case-control study. Pregnancy Hypertension 20, pages 44-49.
Crossref
Crossref
Helen PerryJulia BinderErkan KalafatStuart JonesBasky ThilaganathanAsma Khalil. (2020) Angiogenic Marker Prognostic Models in Pregnant Women With Hypertension. Hypertension 75:3, pages 755-761.
Crossref
Crossref
Emma J. Flint, A. Sofia Cerdeira, Christopher W. Redman & Manu Vatish. (2019) The role of angiogenic factors in the management of preeclampsia. Acta Obstetricia et Gynecologica Scandinavica 98:6, pages 700-707.
Crossref
Crossref
Alexander EP Heazell, Dexter JL Hayes, Melissa Whitworth, Yemisi Takwoingi, Susan E Bayliss & Clare Davenport. (2019) Biochemical tests of placental function versus ultrasound assessment of fetal size for stillbirth and small-for-gestational-age infants. Cochrane Database of Systematic Reviews 2019:6.
Crossref
Crossref
Ruby Minhas, Danielle Young, Rabab Naseem, Ariel Mueller, Sireesha Chinthala, Joana Lopes Perdigao, Kiang-Teck J. Yeo, Siaw Li Chan, Avery Tung, Julia Bregand White, Sajid Shahul & Sarosh Rana. (2018) Association of antepartum blood pressure levels and angiogenic profile among women with chronic hypertension. Pregnancy Hypertension 14, pages 110-114.
Crossref
Crossref
Sarosh Rana, Saira Salahuddin, Ariel Mueller, Anders H. Berg, Ravi I. Thadhani & S. Ananth Karumanchi. (2018) Angiogenic biomarkers in triage and risk for preeclampsia with severe features. Pregnancy Hypertension 13, pages 100-106.
Crossref
Crossref
A. Lind Malte, N. Uldbjerg, D. Wright & N. Tørring. (2018) Prediction of severe pre‐eclampsia/HELLP syndrome by combination of sFlt‐1, CT‐pro‐ET‐1 and blood pressure: exploratory study. Ultrasound in Obstetrics & Gynecology 51:6, pages 768-774.
Crossref
Crossref
Tuangsit Wataganara, Jarunee Leetheeragul, Suchittra Pongprasobchai, Anuwat Sutantawibul, Chayawat Phatihattakorn & Surasak Angsuwathana. (2018) Prediction and prevention of pre‐eclampsia in Asian subpopulation. Journal of Obstetrics and Gynaecology Research 44:5, pages 813-830.
Crossref
Crossref
John C. Kingdom, Melanie C. Audette, Sebastian R. Hobson, Rory C. Windrim & Eric Morgen. (2018) A placenta clinic approach to the diagnosis and management of fetal growth restriction. American Journal of Obstetrics and Gynecology 218:2, pages S803-S817.
Crossref
Crossref
Siaw Li Chan, Sarosh Rana, Sireesha Chinthala, Saira Salahuddin & Kiang-Teck J. Yeo. (2018) Analytical validation of soluble fms-like tyrosine and placental growth factor assays on B·R·A·H·M·S KRYPTOR Compact Plus automated immunoassay platform. Pregnancy Hypertension 11, pages 66-70.
Crossref
Crossref
U. Vivian UkahJennifer A. HutcheonBeth PayneMatthew D. HaslamManu VatishJ. Mark AnserminoHelen BrownLaura A. MageePeter von Dadelszen. (2017) Placental Growth Factor as a Prognostic Tool in Women With Hypertensive Disorders of Pregnancy. Hypertension 70:6, pages 1228-1237.
Crossref
Crossref